Find Clinical Trials | Cedars-Sinai

217 results found

Urinary Bladder

Bladder Cancer: TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical BCG

This study focuses on individuals who have a diagnosis of high-risk, non-muscle invasive bladder cancer (also referred to as HR-NMIBC or urothelial cancer). The purpose of the study is to compare the effects of ...

Hodgkin's Lymphoma, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia ...

Collecting and Combining Autologous Hematopoietic Stem Cells With (CAR) T-Cell Therapy in Hematological Malignancies

The purpose of this study is to assess the impact of adding blood stem cells to CAR T-cell therapy in an effort to improve cancer treatment. CAR T-cell therapy is a type of treatment in ...

Bones and Joints, Breast, Cervix, Colon, Kidney, Liver, Lung, Melanoma ...

PARG Inhibitor IDE161 in Advanced Solid Tumors

This study focuses on individuals who have a solid tumor cancer (not a blood cancer) that has worsened and has not responded to at least one prior cancer treatment. The purpose of the study is ...

Other Hematopoietic

Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Large B-Cell Lymphoma

This study focuses on patients with relapsed or refractory large b-cell lymphoma (LBCL). Relapsed means the LBCL has returned after it responded to treatment; refractory means the LBCL did not respond to earlier treatment. The ...

Non-Hodgkin's Lymphoma

IMPT-314 in Aggressive B-Cell Non-Hodgkin Lymphoma

The purpose of this study is to evaluate experimental gene-modified immune cells called IMPT-314 for the treatment of lymphomas that have either come back after treatment or have stopped responding to treatment. IMPT-314 is a ...